Vivesto Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Vivesto's earnings have been declining at an average annual rate of -5.9%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 18.3% per year.

Belangrijke informatie

-5.9%

Groei van de winst

8.4%

Groei van de winst per aandeel

Biotechs Groei van de industrie0.7%
Inkomstengroei-18.3%
Rendement op eigen vermogen-55.3%
Nettomarge-1,496.7%
Volgende winstupdate21 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

Apr 25
Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

Aug 21
Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

Opbrengsten en kosten

Hoe Vivesto geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

OM:VIVE Opbrengsten, kosten en inkomsten (SEK Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 247-99570
31 Mar 247-117730
31 Dec 237-129840
30 Sep 232-284870
30 Jun 233-340930
31 Mar 233-351950
31 Dec 223-357960
30 Sep 2213-1401010
30 Jun 2224-991070
31 Mar 2229-1181110
31 Dec 2129-1331240
30 Sep 21-184-348880
30 Jun 21-195-3541080
31 Mar 21-199-3761460
31 Dec 204-2101850
31 Oct 20205-59830
31 Jul 20205-24730
30 Apr 20206-112260
31 Jan 204-1961130
31 Oct 196-167850
31 Jul 199-210600
30 Apr 1910-201520
31 Jan 1914-1541070
31 Oct 1813-1531060
31 Jul 1813-1171060
30 Apr 1812-1181090
31 Jan 1810-1281150
31 Oct 1710-1391260
31 Jul 178-1551350
30 Apr 177-1601390
31 Jan 177-1511390
31 Oct 1616-1371410
31 Jul 1619-1391480
30 Apr 1623-1421560
31 Jan 1626-1391500
31 Oct 1518-1411360
31 Jul 1519-1241220
30 Apr 1519-1171110
31 Jan 1523-1251230
31 Oct 1426-1281290
31 Jul 1428-1201240
30 Apr 1430-1051200
31 Jan 1430-901090

Kwaliteitswinsten: VIVE is currently unprofitable.

Groeiende winstmarge: VIVE is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: VIVE is unprofitable, and losses have increased over the past 5 years at a rate of 5.9% per year.

Versnelling van de groei: Unable to compare VIVE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: VIVE is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).


Rendement op eigen vermogen

Hoge ROE: VIVE has a negative Return on Equity (-55.26%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden